Mylan Institutional LLC Recalls

Overview of recall records associated with Mylan Institutional LLC, including dates, categories and classifications where available.

3recall records

Jun 9, 2021latest record date

Sep 9, 2020earliest record date

Recall history in this database

Classification mix: Class I: 2, Class III: 1.

DrugJun 9, 2021

Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials recall — FDA D-0601-2021

Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Class IIIFDA: TerminatedMylan Institutional LLC

DrugSep 9, 2020

Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial recall — FDA D-1576-2020

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection,…

Class IFDA: TerminatedMylan Institutional LLC

DrugSep 9, 2020

Amiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial recall — FDA D-1575-2020

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection,…

Class IFDA: TerminatedMylan Institutional LLC

Understanding this recall history

This page summarizes recall records in which the official source identifies Mylan Institutional LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.